share_log

港股午评 | 三大指数小幅下跌,医药股、餐饮股走俏,药明生物涨近4%,海底捞涨超6%

Hong Kong Stock Afternoon Review | The three major indices fell slightly. Pharmaceutical stocks and catering stocks were popular. Pharmaceutical and Biotech rose nearly 4%, and Haidilao rose more than 6%

Futu News ·  Jan 10 12:09

Futu News reported on January 10 that the three major indices of Hong Kong stocks fell slightly. The Hang Seng Index fell 0.42%, the Science Index fell 0.43%, and the National Index fell 0.3%.

By the midday close, Hong Kong stocks had risen 673, down 966, and closed at 1,341.

On the sector side, TechNet shares had mixed ups and downs. Xiaomi fell nearly 2%, Tencent fell more than 1%, Alibaba fell slightly, Kuaishou rose more than 1%, Bilibili rose nearly 1%, and JD, Meituan, Baidu, and NetEase rose slightly.

Domestic housing stocks and property management stocks mostly declined. Greentown China fell nearly 2%, Ocean Group and Vanke fell more than 1%, Yuexiu Real Estate fell nearly 1%, and Country Garden rose more than 1%.

Auto stocks generally fell, with NIO falling more than 4%, Zero Sports by more than 2%, Great Wall Motors and Ideal Auto falling by nearly 2%, BYD shares falling by more than 1%, and Xiaopeng Motors falling slightly.

Pharmaceutical stocks rose sharply, with BaiGe Shenzhou up more than 6%, Pharmaceutical Biotech up nearly 4%, Genting Xinyao up more than 3%, Kangfang Biotech up nearly 3%, and Pharmaceutical Kangde up more than 2%.

Catering stocks rose partly, with Haidilao up more than 6%, Xiabuxiabu by more than 3%, and Nai Xue's tea rising by more than 1%.

Shipping stocks continued to fall, with COSCO Marine Holdings falling nearly 5%, Haifeng International falling more than 4%, COSCO Haineng falling nearly 3%, and Orient Overseas International falling more than 1%.

On the other side, semiconductor stocks, paper stocks, wind power stocks, and insurance stocks declined one after another, while China Life Insurance and China Taibao all fell by more than 2%.

In terms of individual stocks,$WUXI BIO (02269.HK)$It has risen by nearly 4%, overseas CRO order indicators have improved, and domestic demand is still bottoming out.

$EAST BUY (01797.HK)$It rose more than 2%, and Dong Yuhui's first broadcast of the new GMV broke 100 million.

$INNOVENT BIO (01801.HK)$With an increase of more than 4%, the first phase III clinical study of the weight loss drug Maxidopeptide reached the main end point and all key secondary endpoints.

$COSCO SHIP HOLD (01919.HK)$It fell nearly 5%, and net profit for the whole year is expected to decrease by about 78.4% year on year to 23.889 billion yuan.

$HAIDILAO (06862.HK)$With an increase of more than 6%, leading restaurants are expected to drive performance growth through store expansion.

Top 20 half-day turnover

Edit/Chris

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment